Invention Grant
- Patent Title: Indoleamine 2,3-dioxygenase inhibitor, method for preparation and use thereof
-
Application No.: US15733410Application Date: 2018-12-13
-
Publication No.: US11214554B2Publication Date: 2022-01-04
- Inventor: Xiaoqing Zhang , Zhichun Song , Jinyuan Bao
- Applicant: NANJING HUAWE MEDICINE TECHNOLOGY GROUP CO., LTD.
- Applicant Address: CN Jiangsu
- Assignee: NANJING HUAWE MEDICINE TECHNOLOGY GROUP CO., LTD.
- Current Assignee: NANJING HUAWE MEDICINE TECHNOLOGY GROUP CO., LTD.
- Current Assignee Address: CN Jiangsu
- Agency: Novick, Kim & Lee, PLLC
- Agent Allen Xue
- Priority: CN201810058615.8 20180122
- International Application: PCT/CN2018/120771 WO 20181213
- International Announcement: WO2019/141027 WO 20190725
- Main IPC: C07D271/08
- IPC: C07D271/08 ; C07D413/04 ; C07D413/08 ; C07D417/12
Abstract:
A novel indoleamine 2,3-dioxygenase inhibitor and/or its pharmaceutically acceptable salts can used, in the preparation of a drug for indoleamine 2,3-dioxygenase (IDO) related diseases, such as cancer, Alzheimer's, depression, cataract, etc.
Public/Granted literature
- US20210094924A1 INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR, METHOD FOR PREPARATION AND USE THEREOF Public/Granted day:2021-04-01
Information query
